| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.58 | 0.002 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.003 |